Validation of an Magnetic Resonance Imaging Acquisition and Review Protocol for Alzheimer's Disease and Related Disorders

Abstract

Purpose Magnetic resonance imaging (MRI) of the brain allows for the identification of structural lesions typical of Alzheimer's disease (AD), the main cause of dementia. However, to have a clinical impact, it is imperative that acquisition and reporting of this MRI-based evidence be standardized, ensuring the highest possible reliability and reproducibility. Our objective was to validate a systematic radiological MRI acquisition and review process in the context of AD. Methods We included 100 individuals with a suspicion of dementia due to AD for whom MRI were acquired using our proposed protocol of clinically achievable acquisitions and used a unified reading grid to gather semi-quantitative evidence guiding diagnostic. MRIs were read by 3 raters with different experience levels. Interrater reliability was measured using Cohen's kappa statistic. Results Interrater reliability average for lesions occupying space, hemorrhage, or ischemia, was respectively 0.754, 0.715, and 0.501. Average reliability of white matter hyperintensity burden (Fazekas), global cortical atrophy, and temporal lobe atrophy (Scheltens) scales was 0.687, 0.473, and 0.621 (right)/0.599 (left), respectively. The kappas for regional cortical atrophy (frontal, parietal, occipital, temporal, and posterior cingulum) varied from 0.281–0.678. The average MRI reading time varied between 1.43-5.22 minutes. Conclusions The presence of space occupying lesions, hemorrhagic or ischemic phenomena, and radiological scales have a good interrater reproducibility in MRI. Coupled with standardized acquisitions, such a protocol should be used when evaluating possible dementias, especially those due to probable AD.

Aducanumab: Appropriate Use Recommendations Update

“…Patients should be excluded from treatment if they have evidence of acute or subacute hemorrhage, a macrohemorrhage, cortical infarction larger than 1.5 cm, one lacunar infarction larger than 1.5 cm, more than four microhemorrhages, more than one area of superficial siderosis, or extensive white matter disease indicative of ischemic injury ( Table 2 ). Substantial white matter pathology of concern includes those with irregular periventricular white matter hyperintensities extending into deep white matter and moderate or advanced confluent areas of deep white matter hyperintensities ( 14 , 15 ). MRI sequences appropriate for this baseline assessment include T1, T2 or fluid attenuated inversion recovery (FLAIR), T2* gradient recalled echo (GRE) sequences or susceptibility weighted imaging (SWI), if available, and diffusion weighted imaging (DWI).…”

Automated age- and sex-specific volumetric estimation of regional brain atrophy: workflow and feasibility

“…Normal aging is accompanied with decrease of brain volume [1]. The evaluation of deviations of regional brain volume beyond this physiological atrophy from cranial MRI is challenging and entails immense variations across readers [2]. Nevertheless, the detection of regional brain atrophy and accelerated brain aging is substantial for radiologic assessment, in particular in the diagnostic workup of neurodegenerative diseases.…”